BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12140375)

  • 1. Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines.
    Johansson M; Takasaki A; Lenner L; Arstrand K; Kågedal B
    Melanoma Res; 2002 Jun; 12(3):193-200. PubMed ID: 12140375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro.
    Eberle J; Garbe C; Wang N; Orfanos CE
    Pigment Cell Res; 1995 Dec; 8(6):307-13. PubMed ID: 8789739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
    Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Schenk F; Franzke A; Atzpodien J; Buer J
    Melanoma Res; 2000 Aug; 10(4):355-62. PubMed ID: 10985670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
    Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U
    Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating melanoma cells by RT-PCR amplification of three different melanocyte-specific mRNAs in a mouse model.
    Tsukamoto K; Hirata S; Osada A; Kitamura R; Shimada S
    Pigment Cell Res; 2000 Jun; 13(3):185-9. PubMed ID: 10885678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
    Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
    Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
    de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy.
    Schmidt H; Sorensen BS; Fode K; Nexo E; von der Maase H
    Melanoma Res; 2005 Oct; 15(5):409-16. PubMed ID: 16179868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human melanoma cell lines show little relationship between expression of pigmentation genes and pigmentary behaviour in vitro.
    Eberle J; Wagner M; MacNeil S
    Pigment Cell Res; 1998 Jun; 11(3):134-42. PubMed ID: 9730320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
    Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
    Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.
    Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
    Mod Pathol; 2008 Mar; 21(3):326-33. PubMed ID: 18204435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases].
    Riccioni L; Farabegoli P; Nanni O; Morigi F; Polverelli M; Landi G; Giangaspero F
    Pathologica; 2002 Aug; 94(4):190-5. PubMed ID: 12325417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression.
    Strohal R; Mosser R; Kittler H; Wolff K; Jansen B; Brna C; Stingl G; Pehamberger H
    Melanoma Res; 2001 Oct; 11(5):543-8. PubMed ID: 11595894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
    Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
    J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma.
    Schmidt H; Sørensen BS; von der Maase H; Bang C; Agger R; Hokland M; Nexo E
    Melanoma Res; 2002 Dec; 12(6):585-92. PubMed ID: 12459648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gp100 mRNA is more sensitive than tyrosinase mRNA for RT-PCR amplification to detect circulating melanoma cells in peripheral blood of melanoma patients.
    Tsukamoto K; Ueda M; Hirata S; Osada A; Kitamura R; Takahashi T; Ichihashi M; Shimada S
    J Dermatol Sci; 2000 Jun; 23(2):126-31. PubMed ID: 10808130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1.
    Luo D; Chen H; Jimbow K
    Exp Cell Res; 1994 Jul; 213(1):231-41. PubMed ID: 8020595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RT-PCR detection of tyrosinase, gp100, MART1/Melan-A, and TRP-2 gene transcripts in peripheral blood of melanoma patients.
    Samija M; Juretić A; Solarić M; Samija I; Bingulac-Popović J; Grahovac B; Stanec M; Oresić V
    Croat Med J; 2001 Aug; 42(4):478-83. PubMed ID: 11471202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma.
    Brownbridge GG; Gold J; Edward M; MacKie RM
    Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.